The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor
2014 ◽
Vol 135
(4)
◽
pp. 1002-1006
◽
2010 ◽
Vol 70
(4)
◽
pp. 1625-1634
◽
2013 ◽
Vol 12
(11)
◽
pp. 2541-2558
◽
2012 ◽
Vol 31
(3-4)
◽
pp. 807-814
◽
2010 ◽
2014 ◽
2007 ◽
Vol 16
(3)
◽
pp. 263-267
◽